XML 41 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings Per Share (Tables)
9 Months Ended
Nov. 01, 2020
Earnings Per Share [Abstract]  
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

We expect to continue to grant these types of awards annually in the future. The following table sets forth the number of outstanding restricted stock awards and RSUs and PSUs, net of forfeitures and vested shares, as of the fiscal period-end dates indicated:

 

   

November 1,

   

February 2,

 
   

2020

   

2020

 
                 

Restricted shares

    55       46  

RSUs and PSUs

    159       76  
      214       122  

 

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] The following table sets forth the computation of basic and diluted earnings per share:
   

Thirteen Weeks Ended

   

Thirty-Nine Weeks Ended

 
   

November 1,

   

November 3,

   

November 1,

   

November 3,

 
   

2020

   

2019

   

2020

   

2019

 
                                 

Net income/(loss)

  $ 10,093     $ 3,920     $ (18,952 )   $ 10,067  

   Less: Unvested participating restricted stock dividends

    9       7       26       18  

            Net earnings allocated to unvested participating restricted stock

    47       16       -       33  

Earnings/(loss) available for common shareholders

    10,037       3,897       (18,978 )     10,016  
                                 

Weighted average shares outstanding for basic earnings per share

    11,833       11,789       11,818       11,782  

Dilutive effect of unvested restricted stock, RSU and PSU awards

    106       27      
*
      39  

   Weighted average shares outstanding for diluted earnings per share

    11,939       11,816       11,818       11,821  
                                 

Basic earnings/(loss) per share

  $ 0.85     $ 0.33     $ (1.61 )   $ 0.85  
                                 

Diluted earnings/(loss) per share

  $ 0.84     $ 0.33     $ (1.61 )   $ 0.85  

 

*Due to the fiscal 2021 year-to-date net loss, approximately 92,000 shares would have been antidilutive and are therefore excluded from the calculation of earnings per share for the thirty-nine weeks ended November 1, 2020.